# Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)

> **NCT06380491** · PHASE4 · RECRUITING · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 50 (estimated)

## Conditions studied

- Obstructive Sleep Apnea of Adult

## Interventions

- **DRUG:** Melatonin 3 MG Oral Tablet

## Key facts

- **NCT ID:** NCT06380491
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-22
- **Primary completion:** 2027-12-22
- **Final completion:** 2028-01-22
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06380491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06380491, "Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06380491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*